Modification of pre-mRNA splicing by antisense oligonucleotides - PubMed (original) (raw)
Affiliations
- PMID: 9360712
Review
Modification of pre-mRNA splicing by antisense oligonucleotides
R Kole. Acta Biochim Pol. 1997.
Abstract
Antisene oligonucleotides have been extensively studied as agents that inhibit the expression of undesirable genes in a sequence specific manner. Results reviewed in this article show that antisene oligonucleotides can also restore the expression of genes inactivated by mutations causing genetic diseases. In this novel application, antisene oligonucleotides block aberrant splice sites created by the mutations, forcing the spliceosomes to form at correct splice sites, thus restoring the proper splicing pathway and consequently the activity of the damaged gene.
Similar articles
- Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
Hodges D, Crooke ST. Hodges D, et al. Mol Pharmacol. 1995 Nov;48(5):905-18. Mol Pharmacol. 1995. PMID: 7476922 - Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H, Sambade MJ, Agrawal S, Kole R. Sierakowska H, et al. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12840-4. doi: 10.1073/pnas.93.23.12840. Proc Natl Acad Sci U S A. 1996. PMID: 8917506 Free PMC article. - Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A, Mostafa A, Youssry I, Gabr H, Mansour IM, El-Tablawy M, Aziz M, Hussein IR. El-Beshlawy A, et al. J Pediatr Hematol Oncol. 2008 Apr;30(4):281-4. doi: 10.1097/MPH.0b013e3181639afe. J Pediatr Hematol Oncol. 2008. PMID: 18391696 - Making antisense of splicing.
Garcia-Blanco MA. Garcia-Blanco MA. Curr Opin Mol Ther. 2005 Oct;7(5):476-82. Curr Opin Mol Ther. 2005. PMID: 16248283 Review. - Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
Mourich DV, Iversen PL. Mourich DV, et al. Curr Opin Mol Ther. 2009 Apr;11(2):124-32. Curr Opin Mol Ther. 2009. PMID: 19330718 Review.
Cited by
- Therapeutic potential of splice-switching oligonucleotides.
Bauman J, Jearawiriyapaisarn N, Kole R. Bauman J, et al. Oligonucleotides. 2009 Mar;19(1):1-13. doi: 10.1089/oli.2008.0161. Oligonucleotides. 2009. PMID: 19125639 Free PMC article. Review. - hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing.
Goehe RW, Shultz JC, Murudkar C, Usanovic S, Lamour NF, Massey DH, Zhang L, Camidge DR, Shay JW, Minna JD, Chalfant CE. Goehe RW, et al. J Clin Invest. 2010 Nov;120(11):3923-39. doi: 10.1172/JCI43552. Epub 2010 Oct 25. J Clin Invest. 2010. PMID: 20972334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources